P wave dispersion; Arrhythmia; Exacerbations; COPD Summary Purpose: Acute exacerbations of chronic obstructive pulmonary disease (COPD) sometimes appear to occur without a precipitating cause. Heterogeneous repolarization and arrhythmias occur in COPD patients. Given the close inter-relation between heart and lung, we hypothesized that unrecognized arrhythmias might be precipitants of acute exacerbations. Methods: Electrocardiograms (ECG) of thirty patients during acute exacerbations were compared with ECG during stable phase. P wave dispersion was used to assess atrial depolarization heterogeneity, and dispersion of QT interval to assess ventricular repolarization. p < 0.05 was considered significant. Frequent exacerbations were defined as two or more exacerbations in a year. Results: Mean age of patients was 70.3 AE 11.8 SD years. P wave dispersion was greater during acute exacerbation than during stable phase (56.7 AE 19.2 vs 47.7 AE 15.9 ms, p Z 0.009). There was a trend toward greater QTc dispersion (108.3 AE 61.7 vs 90.3 AE 47.0 ms, p Z 0.13) in acute exacerbation compared to stable phase. Sixteen (53%) had frequent exacerbations. There was a significant difference in PR interval during stable phase between those with frequent exacerbations and those without (163.9 þ 17.4 vs. 145.1 þ 22.8; p Z 0.02). The P wave dispersion during stable phase was greater in those with frequent exacerbations, but did not reach statistical significance (52.6 þ 18.8 vs. 42.2 þ 9.8 ms; p Z 0.06). Conclusions: P wave dispersion is more in the acute phase than in stable phase, and is greater in patients with more frequent exacerbations. This does not prove, but suggests an intriguing possibility that P wave dispersion predates acute exacerbations. This might be a new target for prediction, prevention and therapy of acute exacerbations of COPD. ª
Introduction
Acute exacerbations of chronic obstructive pulmonary disease (COPD) are associated with considerable morbidity and mortality. 1 They are thought to be usually due to infections, air pollution, change in humidity, and noncompliance with medications. 2 About a third, however appear to occur without a precipitating cause. 2 There is increasing recognition that COPD is not a simple respiratory disorder. The close inter-relation between the lungs and the heart is affected in COPD, in the form of high rates of diastolic dysfunction, recognition of arrhythmias like multifocal atrial tachycardias and cor pulmonale. 3, 4 Heterogeneous ventricular repolarization and ventricular arrhythmias have been shown to occur in COPD patients. 5e8 QT dispersion is more in stable COPD patients compared to age and sex matched normal controls. 8 Moreover, arrhythmias are commonly seen in patients with acute exacerbations. 9, 10 These arrhythmias are commonly believed to be due to disturbances in oxygen, carbon dioxide and pH. 6, 11 Autonomic dysfunction has also been observed. 5, 12 It is not known if the arrhythmias are secondary to exacerbations and the resulting acid base disturbances; or whether arrhythmias lead to exacerbation. In the current study, recognizing the close inter-relation between heart and lung, and the relation between vascular congestion and bronchial hyper-reactivity, we hypothesized that unrecognized arrhythmias might be precipitants of acute exacerbations. We sought to test this hypothesis by comparing surface electrocardiogram (ECG) indices of heterogeneity in atrial depolarization and ventricular repolarization in subjects with acute exacerbation of COPD with the same indices when in stable phase, and also between subjects with frequent and infrequent exacerbations. We further attempted to determine if the repolarization abnormalities primarily arose from the strained right side of the heart, defining a right sided electropathy.
Methods
Consecutive patients with principal discharge diagnosis of acute exacerbation of COPD who had been hospitalized at a tertiary care center were included. The study was exempted from review by the Institutional Review Board because all data was de-identified at the time of analysis. The requirement for informed patient consent was waived by the Institutional Review Board. Only those patients with spirometry confirmed diagnosis of COPD were included. 13 Those with secondary diagnoses of congestive heart failure, coronary artery disease, chronic renal failure, chronic respiratory conditions other than COPD, carcinoma lung and those with evidence of pneumonia on chest radiograph were excluded. Patients with chronic atrial fibrillation; multifocal tachycardia; and conditions which made assessment of QT dispersion (QTd) imprecise, like bundle branch block and hypokalemia, were excluded. Those who required invasive mechanical ventilation were excluded as this could cause right ventricular strain. Patients using drugs that could prolong the QT interval, such as antiarrhythmics (amiodarone, sotalol, procainamide, disopyramide, quinidine), antibiotics (macrolides), and psychiatric medications (tricyclic antidepressants, phenothiazines, haloperidol), were also excluded.
Clinical and demographic data were recorded. This included age; smoking status and number of pack-years; presence of co-morbidities such as diabetes mellitus, hypertension, depression, cerebrovascular disease; and current pulmonary function test results (those within 2 years of admission). Active smokers were defined as those who had smoked within the previous 6 months. Laboratory data recorded included hematocrit, renal function tests, and arterial blood gas analysis obtained within 6 h of hospitalization. Electrolytes potentially affecting QT interval such as potassium and magnesium were measured. Serum calcium was adjusted for serum albumin levels. Serum CPK and troponin were recorded at the time of admission to rule out subtle ischemia.
Patients were followed for the next one year or till next readmission for acute exacerbation of COPD, whichever was longer. The number of readmissions for acute exacerbations in one year after index admission was recorded, and the time to readmission calculated. Frequent exacerbations were defined as two or more hospital visits for acute exacerbations in a year.
Electrocardiogram analyses
The first 12-lead surface electrocardiogram obtained in the emergency department at the time of admission for acute exacerbation and the first electrocardiogram within 12 months on either side of admission when stable but not within 1 month of index admission or exacerbation was used for measurements by a single blinded observer. All ECGs were enlarged to 200% of actual size using a photocopier. All measurements were made manually using an ECG caliper. The QT interval was measured to assess ventricular repolarization. The QT interval was measured from the onset of QRS complex to the end of T wave. In the presence of inverted T waves, the point where the trace returned to baseline (defined as the TeP segment) was taken as the end of the QT interval. In the presence of U wave, the QT interval was deemed to have ended at the lowest point between the T wave and the U wave. 6 In case of unclear T wave termination, the ECG was discarded and the next available ECG was used for measurements. Measurements were made in all 12 leads. The QT dispersion (QTd) was calculated by subtracting the minimum duration of the QT interval from the maximum QT duration. ReR intervals were measured for all leads. All QT intervals were corrected for heart rate using Bazett's formula (QTc Z QT/ OReR. QTc dispersion (QTcd) was similarly calculated. Further, V 1 and V 2 were defined as right sided leads and V 5 and V 6 were defined as left sided leads. The difference in QT duration in these leads were calculated to assess right and left sided QT dispersions. This was to discern if there was a difference in QT dispersion on the right side due to right ventricular strain.
To assess heterogeneity of atrial depolarization, the width of P wave was measured in all 12 leads of the surface ECG. P wave duration was measured from the beginning of the P wave deflection from baseline (TeP segment) to the point where the P wave returned to baseline. P wave dispersion (PWd) was calculated by subtracting the minimum width of the P wave from the max P wave duration. The mean P, QRS and T wave axes were recorded from the electronic data indicated on the ECG record.
Statistical analyses
Continuous variables were expressed as mean AE SD, except for time to readmission for which median was calculated. Categorical variables were expressed as frequencies and percentages. Paired t test was used to compare QT, QTc, QTd, QTcd, Pmax and PWd in patients during acute exacerbation and when stable. Independent t test was used to compare ECG indices and laboratory parameters between patients with frequent and infrequent exacerbations. Finally, Cox proportional hazards regression was used to calculate the effect of PWd on time to readmission, p < 0.05 was considered significant in all cases. All analyses were done using SPSS version 11.5 (SPSS Inc., Chicago, IL).
Results
Thirty patients meeting all inclusion criteria were included in the study. The demographic and clinical data for the study population is shown in Table 1 . Ninety percent were active-or ex-smokers.
Twenty seven (90%) were readmitted for acute exacerbation within a year of index hospitalization, and 7 (23%) of them were readmitted within a month of initial hospitalization. Table 2 describes the electrocardiographic measurements during acute exacerbations and stable phases. The P wave dispersion was significantly greater in acute phase compared to stable phase (56.7 AE 19 vs. 47.7 þ 16 ms; p Z 0.009. See Fig. 1 ). There was a similar trend in QTc dispersion but this did not reach statistical significance. There was no difference between right and left sided QT and QTc dispersions.
Sixteen (53%) had frequent exacerbations. There was a significant difference in PR interval during stable phase between those with frequent exacerbations and those There was also no difference in age, baseline electrolytes and PaO2 between the two groups. There was also no correlation between these variables and P wave dispersion in the stable phase. Results of Cox proportional regression analysis showed that the higher the P wave dispersion, the shorter the time to readmission was (hazards ratio 1.5, 95%CI 0.9 to 2.6; p Z 0.11. See Fig. 3 ).
Discussion
Our study has two important findings. First, there was a significant difference in P wave dispersion in the same subjects in stable and acute phases. Second, the stable phase P wave dispersion was higher in patients with frequent exacerbations than in those without, though this did not reach statistical significance. This latter occurrence was likely due to small numbers of subjects studied. A greater P wave dispersion also shortened the time to readmission by a factor of 1.5. P wave represents atrial depolarization. Increased dispersion represents inhomogeneous conduction and electrical remodeling. This does not prove but is supportive of our hypothesis that unrecognized electrical remodeling and arrhythmias lead to, or cause a predisposition to, acute exacerbations of COPD. This occurrence is biologically plausible. There is a very high incidence of diastolic dysfunction in patients with COPD, though we did not specifically look for this in our study. 3 Any supraventricular arrhythmia, paroxysmal or sustained, can cause impairment of diastolic function. There is a close relationship between vascular congestion in pulmonary vessels and bronchial reactivity.
14 This could lead to decompensation of stable phase in these patients. This has implications in that it leads to new targets for both therapy and prevention. In fact, a large proportion of COPD mortality is not of pulmonary origin. 15 Currently, there are two major hypotheses to explain arrhythmias in COPD. One states that arrhythmias are secondary to hypoxemia, hypercapnia and acid base disturbances. 6 A second hypothesis is that of increased autonomic activity, with both increased sympathetic and lowered parasympathetic activity being proposed. 12 While some studies have speculated that hypoxemia predisposes to autonomic neuropathy, 16, 17 others have failed to find this association. 18, 19 We did not find any correlation between measures of dispersion and acid base disturbances.
Multiple experimental studies have established repolarization dispersion as an arrhythmogenic substrate. 20 , 21 Zulli et al found that QT dispersion was an independent predictor of mortality in patients with COPD. 7 Interestingly, they found that QT dispersion greater than 48 ms and QTc dispersion greater than 55 ms were independent predictors of mortality from respiratory causes. Increased P wave dispersion reflects inhomogeneous atrial impulse conduction, and has been shown to predict development of paroxysmal atrial fibrillation in different patient populations 22e24 Prolonged, inhomogeneous and anisotropic conduction of electrical impulses between atrial fibers predisposes to supraventricular arrhythmias. These are reflected in the surface ECG by prolonged P wave duration and a wide range between the maximum and minimum P wave widths on a 12-lead ECG. 25 Tutek et al showed that the maximum duration of P wave and the P wave dispersion were higher in COPD patients compared to age and sex matched controls. 26 They also found that P wave dispersion was significantly higher in COPD patients with paroxysmal atrial fibrillation when compared to those without paroxysmal atrial fibrillation. P wave dispersion did not correlate with oxygen, carbon dioxide or acid base abnormalities. They concluded that the presence of COPD predicted increased P wave dispersion. Our study is the first to show that P wave dispersion is more in the acute phase than in stable phase, and that P wave dispersion is greater in patients with more frequent exacerbations. This suggests electrical remodeling and strain is more in the acute phase of patients with frequent COPD exacerbations. Our study has many limitations. The sample size was small, and was not based on power calculations. The ECG data was collected retrospectively and the follow up was done prospectively. The ECG measurements were done manually by a single observer. However, this observer was blinded, well qualified to measure ECG intervals, and omitted ECGs not amenable to adequate measurements. Most previous studies have used the same techniques. Also, automatic measurement of QT dispersion has not been shown to be superior to manual measurements. 27 Echocardiogram was not performed in many of these patients, nor invasive tests to assess coronary artery disease. This, however, was not the aim of this study, and we relied on medical records to exclude these variables. While we used easily available surrogate markers of arrhythmias, stronger evidence would come from using event loop recorders in a similar cohort of subjects.
In conclusion, our study showed that P wave dispersion is more in the acute phase than in stable phase, and that P wave dispersion is greater in patients with more frequent exacerbations. This does not prove, but suggests an intriguing possibility that P wave dispersion predates acute exacerbations. This might be a new target for prediction, prevention and therapy of acute exacerbations of COPD.
